Month: October 2022

On 19 October 2022, CPR conducted a virtual presentation to students pursuing a Master of Science in Biotechnology (Coursework) degree from the National University of Singapore’s Department of Biological Sciences.

The talk was organised as part of industry sharing to provide students with the opportunity to build industry connections and gain real-world insights into the field of biotechnology.

In his presentation, CPR CEO Hideaki Shimada shared more about how CPR is leveraging its proprietary technologies to discover promising drug candidates in a shorter amount of time. Explaining the process of drug discovery, he highlighted how monoclonal antibody drugs have the potential to address numerous diseases.

He also pointed out how Singapore’s science ecosystem has been instrumental in helping CPR to drive R&D to create novel therapeutic antibodies. The vibrant R&D scene in Singapore has led to public-private collaboration possibilities and has also attracted promising R&D talent from all over the world.

Overall, the industry exposure from the talk provided participants with fresh perspectives on how their post-graduate degree could lead to various career pathways in the field of biomedical sciences.

On 12 October 2022, we welcomed over 20 students from the National University of Singapore (NUS) to CPR for a lab visit. This visit was part of our annual university-industry collaboration, an initiative which we have embarked on since 2018.  

After organising recruitment webinars for the past two years due to the COVID-19 pandemic, we were glad that we could resume hosting the students in person as Singapore moved into the endemic phase.  

During the visit, NUS students had the opportunity to observe how we conducted our antibody research at our state-of-the-art research facilities. They met some of our employees who shared insights into their work and the importance of innovation and collaboration in this field of work.  

After conducting a presentation where we introduced our work, the students had the chance to ask questions about career pathways in science. The visit provided a platform for us to increase awareness about the innovation process in drug discovery. By sharing our work, we hope we have inspired them to pursue a career in science after they graduate. We look forward to forging closer relationships with tertiary institutions to support the career development of the next generation of aspiring scientists.